Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study

References

• Casellini CM, Vinik AI. Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract 2007;13:550-66
   PubMedGoogle Scholar
• Cole BE. Diabetic peripheral neuropathic pain: recognition and management. Pain Med 2007;8:S27-32
   PubMed Web of Science ®Google Scholar
• Boulton AJ. Management of diabetic peripheral neuropathy. Clin Diabetes 2005;23:9-15
   Google Scholar
• Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62
   PubMed Web of Science ®Google Scholar
• Boulton AJ, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86
   PubMed Web of Science ®Google Scholar
• Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-82
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53
   PubMed Web of Science ®Google Scholar
• Hall GC, Carroll D, Parry D, et al. Epidemiology and treatment of neuropathic pain: The UK primary care perspective. Pain 2006;122:156-62
   PubMed Web of Science ®Google Scholar
• Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8
   PubMed Web of Science ®Google Scholar
• Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc 2006;81:S12-25
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-85
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Woehl A, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006;49:2272-80
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 2006;7:892-900
   PubMed Web of Science ®Google Scholar
• Jude EB, Jacob K. Managing painful neuropathy in diabetes. Pol Arch Med Wewn 2008;118:260-1
   PubMedGoogle Scholar
• Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-22
   PubMed Web of Science ®Google Scholar
• Wu SC, Wrobel JS, Armstrong DG. Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia. Pain Med 2007;8:S33-42
   PubMedGoogle Scholar
• Jensen MP. Review of measures of neuropathic pain. Curr Pain Headache Rep 2006;10:159-66
   PubMedGoogle Scholar
• Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-18
   PubMed Web of Science ®Google Scholar
• Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-56
   PubMed Web of Science ®Google Scholar
• Gutierrez-Alvarez AM, Beltrán-Rodríguez J, Moreno CB. Antiepileptic drugs in treatment of pain caused by diabetic neuropathy. J Pain Symptom Manage 2007;34:201-8
   PubMed Web of Science ®Google Scholar
• Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 2007;335:87
   PubMed Web of Science ®Google Scholar
• Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008;22:417-42
   PubMed Web of Science ®Google Scholar
• Várkonyi T, Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 2008;10:99-108
   PubMed Web of Science ®Google Scholar
• Robinson-Papp J, Simpson DM. Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med 2007;8:S43-9
   PubMed Web of Science ®Google Scholar
• Chong MS, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 2007;67:569-85
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ye W, Boye KS, et al. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J Diabetes Complications 2010;24:9-19
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ye W, Boye KS, et al. Healthcare charges and utilization associated with diabetic neuropathy: impact of type 1 diabetes and presence of other diabetes-related complications and comorbidities. Diabet Med 2009;26:61-9
   PubMedGoogle Scholar
• Boulanger L, Zhao Y, Foster TS, et al. Impact of comorbid depression or anxiety on patterns of treatment and economics outcomes among patients with diabetic peripheral neuropathic pain. Curr Med Res Opin 2009;25:1763-73
   PubMed Web of Science ®Google Scholar
• Boulanger L, Zhao Y, Bao Y, et al. A retrospective study of factors associated with healthcare resource use and costs among patients with diabetic neuropathy. BMC Health Serv Res 2009;9:111
   PubMed Web of Science ®Google Scholar
• Zhao Y, Sun P, Watson P. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin. Curr Med Res Opin 2011;27:785-92
   PubMed Web of Science ®Google Scholar
• Chen S, Wu N, Boulanger L, et al. The relationship between average daily dose, medication adherence, and healthcare costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy. Pain Pract 2010;10:530-9
   PubMedGoogle Scholar
• Wu N, Chen S, Boulanger L, et al. The association of average daily dose of duloxetine on medication adherence and healthcare costs in patients with diabetic peripheral neuropathic pain. J Med Econ 2009;12:192-202
   PubMedGoogle Scholar
• Bureau of Labor Statistics. Consumer Price Index: January 2008
   Google Scholar
• Chaturvedi N. The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract 2007;76:S3-12
   PubMed Web of Science ®Google Scholar
• Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007;8:S50-62
   PubMed Web of Science ®Google Scholar
• Gore M, Dukes E, Rowbotham DJ, et al. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain 2007;11:652-64
   PubMed Web of Science ®Google Scholar